Literature DB >> 8726962

Signal transduction mechanism responsible for changes in axoplasmic transport caused by neurotransmitters.

T Takenaka1, T Kawakami.   

Abstract

Transduction mechanism for modulation of axoplasmic transport by neurotransmitters was studied using cultured mouse superior cervical ganglion cells. The transported particles were analyzed with a computer-assisted video-enhanced differential interference contrast microscope system. Acetylcholine depressed and adrenaline increased axoplasmic transport. GTP-binding proteins linked with both receptors activate or inactivate adenylyl cyclase, thereby altering the intracellular concentration of cyclic AMP. The cyclic AMP activates protein kinase A, which phosphorylates certain enzymes and the enzymes in turn phosphorylate motor proteins. An inhibitor protein kinase A, KT5720, decreases the number of the transported particles. In a stable state the cyclic AMP level stays at a normal level. Treatment with neurotransmitters causes a change in this level, which changes the activity of protein kinase A and thus decreases or enhances the phosphorylation of motor proteins. These changes are involved in the modulation of axoplasmic transport.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726962     DOI: 10.1007/BF02527752

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  The phosphorylation of kinesin regulates its binding to synaptic vesicles.

Authors:  R Sato-Yoshitake; H Yorifuji; M Inagaki; N Hirokawa
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

2.  Cyclic AMP induces changes in distribution and transport of organelles within growth cones of Aplysia bag cell neurons.

Authors:  P Forscher; L K Kaczmarek; J A Buchanan; S J Smith
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

3.  Long-term potentiation of transmitter release induced by adrenaline in bull-frog sympathetic ganglia.

Authors:  K Kuba; E Kumamoto
Journal:  J Physiol       Date:  1986-05       Impact factor: 5.182

4.  Muscarinic receptor-mediated increase in cAMP levels in SK-N-SH human neuroblastoma cells.

Authors:  J Baumgold; P H Fishman
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

Review 5.  The molecular basis of muscarinic receptor diversity.

Authors:  T I Bonner
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

6.  Different sensitivities to agonist of muscarinic acetylcholine receptor subtypes.

Authors:  H Bujo; J Nakai; T Kubo; K Fukuda; I Akiba; A Maeda; M Mishina; S Numa
Journal:  FEBS Lett       Date:  1988-11-21       Impact factor: 4.124

7.  Intracellular observations on the disinhibitory action of acetylcholine in the hippocampus.

Authors:  Y Ben-Ari; K Krnjević; W Reinhardt; N Ropert
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

8.  Effect of neurotransmitters on axoplasmic transport: acetylcholine effect on superior cervical ganglion cells.

Authors:  T Takenaka; T Kawakami; N Hikawa; Y Bandou; H Gotoh
Journal:  Brain Res       Date:  1992-08-21       Impact factor: 3.252

9.  Effect of neurotransmitters on axoplasmic transport: how adrenaline affects superior cervical ganglion cells.

Authors:  T Takenaka; T Kawakami; H Hori; Y Bandou
Journal:  Brain Res       Date:  1994-04-18       Impact factor: 3.252

10.  Mechanism of long-term potentiation of transmitter release induced by adrenaline in bullfrog sympathetic ganglia.

Authors:  E Kumamoto; K Kuba
Journal:  J Gen Physiol       Date:  1986-05       Impact factor: 4.086

View more
  1 in total

1.  Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells.

Authors:  Hiromi Hiruma; Ayako Saito; Tatsumi Kusakabe; Toshifumi Takenaka; Tadashi Kawakami
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.